Clinical and histopathological features of myeloid neoplasms with concurrent Janus kinase 2 (<i>JAK2</i>) V617F and KIT proto‐oncogene, receptor tyrosine kinase (<i>KIT</i>) D816V mutations
Nicole Naumann(Heidelberg University), Juliana Schwaab(Heidelberg University), Mohamad Jawhar(Heidelberg University), Lukas Reiter(Biognosys (Switzerland)), Claire Oni(Guy's and St Thomas' NHS Foundation Trust), Andreas Reiter(Heidelberg University), Deepti Radia(Guy's and St Thomas' NHS Foundation Trust), Vito Dangelo(Heidelberg University), Nicholas C.P. Cross(Wessex Regional Genetics Laboratory), Georgia Metzgeroth(Heidelberg University), Claire Harrison(University of Namur), Karl Sotlar(University of Tübingen), Johannes Lübke(Heidelberg University), Jason Gotlib(Stanford University), Sebastian Kreil(Heidelberg University), William Shomali(Stanford Medicine), Hans‐Peter Horny(Ludwig-Maximilians-Universität München), Peter Valent(Medical University of Vienna), Wolf‐Karsten Hofmann(Heidelberg University), Alice Fabarius(Heidelberg University)
Cited by 17
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.7k
Clinical and biological implications of driver mutations in myelodysplastic syndromes
|Blood|2013|1.8k
Somatic <i>CALR</i> Mutations in Myeloproliferative Neoplasms with Nonmutated <i>JAK2</i>
|New England Journal of Medicine|2013|1.7k
Extending the Limits of Quantitative Proteome Profiling with Data-Independent Acquisition and Application to Acetaminophen-Treated Three-Dimensional Liver Microtissues
|Molecular & Cellular Proteomics|2015|1.3k
Somatic<i>SF3B1</i>Mutation in Myelodysplasia with Ring Sideroblasts
|New England Journal of Medicine|2011|1.2k